Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $1.3B |
| Sales growthchange from the year before | +25.6% |
| Gross marginshare of sales left after the direct cost of what it sells | 40.6% |
| Operating marginshare of sales left after running the business | 20.9% |
| Net marginshare of sales kept as profit | 6.5% |
| Free-cash-flow marginspare cash generated per $100 of sales | 17.8% |
| Return on invested capitalprofit made on each $100 put into the business | 43.4% |
| Return on equityprofit vs. shareholders' accounting value | 17.0% |
| Change in share countnegative = the company is buying back its shares | +17.2% |
2 insiders sold $1.1M on the open market.
| Das SanjivPresident | SoldAug 3 | 21,289 shat $22.00 · $468K |
| Rosen TamiDirector | SoldAug 3 | 28,181 shat $21.98 · $619K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy